Editorial Comment to Impact of low-dose tadalafil on adverse events after low-dose-rate brachytherapy for prostate cancer: A bi-center randomized open-label trial

Int J Urol. 2021 Apr;28(4):438-439. doi: 10.1111/iju.14511. Epub 2021 Feb 7.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Brachytherapy* / adverse effects
  • Erectile Dysfunction*
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / radiotherapy
  • Tadalafil / adverse effects

Substances

  • Tadalafil